MENU
IRMD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

IRMD stock forecast, quote, news & analysis

iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them... Show more

IRMD
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for IRMD with price predictions
Aug 18, 2026

IRMD in downward trend: 10-day moving average broke below 50-day moving average on August 03, 2026

The 10-day moving average for IRMD crossed bearishly below the 50-day moving average on August 03, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IRMD as a result. In of 113 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for IRMD turned negative on July 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .

IRMD moved below its 50-day moving average on July 31, 2026 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for IRMD moved below the 200-day moving average on August 17, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for IRMD entered a downward trend on August 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IRMD advanced for three days, in of 270 cases, the price rose further within the following month. The odds of a continued upward trend are .

IRMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.989) is normal, around the industry mean (10.971). P/E Ratio (48.866) is within average values for comparable stocks, (70.294). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.991). Dividend Yield (0.009) settles around the average of (0.017) among similar stocks. P/S Ratio (13.038) is also within normal values, averaging (31.248).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. IRMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

A.I.Advisor
published Dividends

IRMD is expected to pay dividends on August 28, 2026

iRadimed Corp IRMD Stock Dividends
A dividend of $0.20 per share will be paid with a record date of August 28, 2026, and an ex-dividend date of August 14, 2026. The last dividend of $0.20 was paid on May 29. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.99B. The market cap for tickers in the group ranges from 1.86K to 194.98B. ABT holds the highest valuation in this group at 194.98B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was 2%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was -6%. PFSA experienced the highest price growth at 74%, while VNRX experienced the biggest fall at -34%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was -30%. For the same stocks of the Industry, the average monthly volume growth was -6% and the average quarterly volume growth was 2%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 49
P/E Growth Rating: 74
Price Growth Rating: 58
SMR Rating: 89
Profit Risk Rating: 94
Seasonality Score: -5 (-100 ... +100)
View a ticker or compare two or three
IRMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a provider of non-magnetic intravenous infusion pump systems

Industry MedicalNursingServices

Profile
Details
Industry
Medical Specialties
Address
12705 Ingenuity Drive
Phone
+1 407 677-8022
Employees
166
Web
https://www.iradimed.com
IRMD in downward trend: 10-day moving average broke below 50-day moving average on August 03, 2026